CA1322715C - Utilisation d'un tripeptide et d'un de ses composes comme agent de stimulation de l'immunite - Google Patents

Utilisation d'un tripeptide et d'un de ses composes comme agent de stimulation de l'immunite

Info

Publication number
CA1322715C
CA1322715C CA000534201A CA534201A CA1322715C CA 1322715 C CA1322715 C CA 1322715C CA 000534201 A CA000534201 A CA 000534201A CA 534201 A CA534201 A CA 534201A CA 1322715 C CA1322715 C CA 1322715C
Authority
CA
Canada
Prior art keywords
arg
tripeptide
ala
cells
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000534201A
Other languages
English (en)
Inventor
Brunetto Brunetti
Marco Prada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ellem Industria Farmaceutica SpA
Original Assignee
Ellem Industria Farmaceutica SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ellem Industria Farmaceutica SpA filed Critical Ellem Industria Farmaceutica SpA
Application granted granted Critical
Publication of CA1322715C publication Critical patent/CA1322715C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA000534201A 1986-04-09 1987-04-08 Utilisation d'un tripeptide et d'un de ses composes comme agent de stimulation de l'immunite Expired - Fee Related CA1322715C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT20027/86A IT1188646B (it) 1986-04-09 1986-04-09 Tripeptide ad attivita' immunostimolante
IT20027A/86 1986-04-09

Publications (1)

Publication Number Publication Date
CA1322715C true CA1322715C (fr) 1993-10-05

Family

ID=11163225

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000534201A Expired - Fee Related CA1322715C (fr) 1986-04-09 1987-04-08 Utilisation d'un tripeptide et d'un de ses composes comme agent de stimulation de l'immunite

Country Status (17)

Country Link
JP (1) JPH0645637B2 (fr)
KR (1) KR870010080A (fr)
AR (1) AR242799A1 (fr)
AT (1) ATA88387A (fr)
AU (1) AU597048B2 (fr)
BE (1) BE1000263A4 (fr)
CA (1) CA1322715C (fr)
CH (1) CH676467A5 (fr)
DE (1) DE3712050A1 (fr)
ES (1) ES2003043A6 (fr)
FR (1) FR2597107B1 (fr)
GB (1) GB2189491B (fr)
GR (1) GR870568B (fr)
IE (1) IE59806B1 (fr)
IT (1) IT1188646B (fr)
NL (1) NL8700827A (fr)
SE (1) SE8701457L (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2058553C1 (ru) * 1994-03-18 1996-04-20 Иван Николаевич Головистиков Способ определения супрессорного звена иммунного статуса человека
RU2056852C1 (ru) * 1994-03-18 1996-03-27 Иван Николаевич Головистиков Средство для лечения аутоиммунных заболеваний с иммунодефицитом супрессоров и способ лечения аутоиммунных заболеваний
GB0130285D0 (en) * 2001-12-19 2002-02-06 Astrazeneca Ab Chemical process
GB0130286D0 (en) * 2001-12-19 2002-02-06 Astrazeneca Ab Chemical process

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3778426A (en) * 1970-12-16 1973-12-11 Research Corp Therapeutically useful polypeptides
US4215112A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Tripeptides and methods

Also Published As

Publication number Publication date
SE8701457L (sv) 1987-10-10
IT1188646B (it) 1988-01-20
NL8700827A (nl) 1987-11-02
ES2003043A6 (es) 1988-10-01
CH676467A5 (fr) 1991-01-31
IE59806B1 (en) 1994-04-06
GB8708492D0 (en) 1987-05-13
ATA88387A (de) 1996-05-15
GB2189491A (en) 1987-10-28
FR2597107B1 (fr) 1991-02-22
JPH0645637B2 (ja) 1994-06-15
IT8620027A0 (it) 1986-04-09
IE870881L (en) 1987-10-09
BE1000263A4 (fr) 1988-09-27
AU597048B2 (en) 1990-05-24
AU7118287A (en) 1987-10-15
FR2597107A1 (fr) 1987-10-16
AR242799A1 (es) 1993-05-31
GB2189491B (en) 1990-02-21
DE3712050C2 (fr) 1992-02-13
DE3712050A1 (de) 1987-10-15
JPS62267296A (ja) 1987-11-19
GR870568B (en) 1987-08-12
IT8620027A1 (it) 1987-10-09
KR870010080A (ko) 1987-11-30
SE8701457D0 (sv) 1987-04-07

Similar Documents

Publication Publication Date Title
US4428938A (en) Peptides affecting the immune regulation and a process for their preparation
KR100623104B1 (ko) 감마-글루타밀 및 베타-아스파르틸을 함유하는 면역조절화합물 및 그의 제조 방법
IE60870B1 (en) Tripeptides and pharmaceutical compositions containing them
Welte et al. Human interleukin 2: biochemistry, physiology, and possible pathogenetic role in immunodeficiency syndromes
US5079231A (en) Immunostimulating peptides, a process for their preparation and pharmaceutical compositions containing them
RU2362579C1 (ru) Фармацевтическая композиция на основе пептида, обладающего противоопухолевым действием
CA1322715C (fr) Utilisation d'un tripeptide et d'un de ses composes comme agent de stimulation de l'immunite
CA1315478C (fr) Tripeptide a activite immunostimulatrice
US4487764A (en) New peptides and a process for their preparation
AT402822B (de) Sdk peptide, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
US5225400A (en) Immunostimulating peptides, a process for their preparation and pharmaceutical compositions containing them
ES2350039T3 (es) Compuestos inmunomoduladores que contienen gamma-glutamilo y beta-aspartilo y métodos con ellos.
US4478828A (en) Nonapeptide having immunostimulative activity, process for the preparation thereof, and its use

Legal Events

Date Code Title Description
MKLA Lapsed